Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury

Abstract

Statins are standard therapy for the treatment of lipid disorders, and the field of redox biology accepts that statins have antioxidant properties. Our aim in this report was to consider the pleiotropic effects of atorvastatin, pravastatin and simvastatin administered prior to endotoxin-induced acute lung injury. Male mice were divided into 5 groups and intraperitoneally injected with LPS (10 mg/kg), LPS plus atorvastatin (10 mg/kg/day; A + LPS group), LPS plus pravastatin (5 mg/kg/day; P + LPS group) or LPS plus simvastatin (20 mg/kg/day; S + LPS group). The control group received saline. All mice were sacrificed one day later. There were fewer leukocytes in the P + LPS and S + LPS groups than in the LPS group. MCP-1 cytokine levels were lower in the P + LPS group, while IL-6 levels were lower in the P + LPS and S + LPS groups. TNF-α was lower in all statin-treated groups. Levels of redox markers (superoxide dismutase and catalase) were lower in the A + LPS group (p < 0.01). The extent of lipid peroxidation (malondialdehyde and hydroperoxides) was reduced in all statin-treated groups (p < 0.05). Myeloperoxidase was lower in the P + LPS group (p < 0.01). Elastance levels were significantly greater in the LPS group compared to the statin groups. Our results suggest that atorvastatin and pravastatin but not simvastatin exhibit anti-inflammatory and antioxidant activity in endotoxin-induced acute lung injury.

Oxidative stress in severe pulmonary trauma in critical ill patients. Antioxidant therapy in patients with multiple trauma — a review

“…Eicosapentaenoic acid -enriched phospholipids extracted from sea cucumber Cucumaria frondosa, also has an inhibition effect on the reactive oxygenated species [89,[98][99][100][101][102][103][104][105]. Wu et al [89] remarks that this antioxidant compound alters the metabolic way of the mitochondrial apoptosis [89].…”

Simvastatin Reduces Burn Injury-induced Splenic Apoptosis via Downregulation of the TNF-α/NF-κB Pathway

“…Simvastatin is a cholesterol-lowering agent that reduces local and systemic inflammatory responses through unknown mechanisms 6 Previous data has suggested that simvastatin blocks the activities of many important proinflammatory cytokines, 7,8 such as TNF-alpha and NF-κB. These cytokines are found to be actively involved in apoptosis.…”

Alternative Interventions to Prevent Oxidative Damage following Ischemia/Reperfusion

“…At low concentrations ROS and RNS work as signaling molecules, while at high concentrations they damage multiple structures, especially mitochondria [23–25, 67, 119, 122, 129, 131]. …”

“…Oxidation of these residues forms reactive sulfenic acid, which in turn forms disulphide bonds with nearby cysteines, and undergoes further oxidation into sulfinic or sulfonic acid, or sulfenamide when nitrogen is present locally. These redox modifications are reversible through reducing systems such as thioredoxin and peroxiredoxin [23–25, 67, 119, 122, 129, 131]. …”

“…As it mediates both DNA repair and redox activation of key transcription factors involved in cellular defense (including AP-1 and NF- κ B), upregulated Ref-1 activity protects DNA from oxidative damage. Consequently, OS conditions can activate detoxification genes such as glutathione S-transferase (GST), NADPH quinone oxidoreductase-1 (NQO1), heme oxygenase-1 (HO1), and ferritin H (FH) [23–25, 67, 119, 122, 129, 131]. …”